Physician profile
Prathima Reddy
NPI 1376540187
$2,258.04
in general payments reported to CMS, 2019-2025
24 companies · $40.16 in 2025
The $40.16 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $975 · 2020: $1,096 · 2021: $146 · 2025: $40.16.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $40.16.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $40.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $434.38 | 2019-2021 | |
| Collegium Pharmaceutical, INC. | $325.77 | 2019-2021 | |
| Allergan, INC. | $245.86 | 2019-2021 | |
| Stimwave Technologies Incorporated | $189.15 | 2020 | |
| Amgen INC. | $170.90 | 2019-2020 | |
| Abbott Laboratories | $150.36 | 2019-2021 | |
| Supernus Pharmaceuticals, INC. | $129.12 | 2019-2020 | |
| Medtronic USA, INC. | $102.91 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $92.31 | 2019 | |
| Novartis Pharmaceuticals Corporation | $71.12 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $53.90 | 2019 | |
| Mdd US Operations, LLC | $48.75 | 2020 | |
| Boston Scientific Corporation | $40.16 | 2025 | Wavewriter Alpha Prime 16 |
| Arbor Pharmaceuticals, INC. | $27.85 | 2019 | |
| Biodelivery Sciences International, INC. | $25.60 | 2019-2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $24.08 | 2019 | |
| Orthogenrx INC. | $22.76 | 2019 | |
| Spr Therapeutics, INC | $18.69 | 2020 | |
| Fidia Pharma USA INC. | $18.00 | 2020 | |
| Zimmer Biomet Holdings, INC. | $15.61 | 2019 | |
| Zyla Life Sciences, INC. | $14.28 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $12.83 | 2021 | |
| Pacira Therapeutics, INC. | $11.99 | 2019 | |
| Shionogi INC | $11.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prathima Reddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.